Search Results

Prepared October 2021 HL/DM Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reaso...

East Region Formulary ERFC Minutes 28 May 2025 Page 1 of 15 East Region Formulary Committee Minutes Date: 28 May 2025 Time: 2.00pm – 4:15pm Location: MS Teams Present: Carla Capaldi Senior Pra...

East Region Formulary ERFC Minutes 9 August 2023 Page 1 of 16 East Region Formulary Committee Minutes Date: 9 August 2023 Time: 2.00pm – 4.30pm Location: MS Teams Present: Ruth Cameron Advan...

East Region Formulary ERFC Minutes 7 June 2023 Page 1 of 17 East Region Formulary Committee Minutes Date: 7 June 2023 Time: 2pm – 4pm Location: MS Teams Present: Jane Browning (Acting) Assoc...

East Region Formulary ERFC Minutes 29 May 2024 Page 1 of 16 East Region Formulary Committee Minutes Date: 29 May 2024 Time: 2.00pm – 5.00pm Location: MS Teams Present: Jane Browning ...

East Region Formulary ERFC Minutes 27 March 2024 Page 1 of 11 East Region Formulary Committee Minutes Date: 27 March 2024 Time: 2.00pm – 4.00pm Location: MS Teams Present: Carla Capaldi ...

East Region Formulary ERFC Minutes 30 November 2022 Page 1 of 21 East Region Formulary Committee Minutes Date: 30 November 2022 Time: 2pm – 4pm Location: MS Teams Present: Alison Casey Senio...

East Region Formulary ERFC Minutes 07 August 2024 Page 1 of 19 East Region Formulary Committee Minutes Date: 07 August 2024 Time: 2.00pm – 4.45pm Location: MS Teams Present: Carla Capaldi ...

TA383 (SMC 101/04) : For the treatment of ankylosing spondylitis

TA187 (SMC 364/07) : For the treatment of fistulising, active Crohn's disease.